NCT01946984View on ClinicalTrials.gov

Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Post-ERCP Acute Pancreatitis.
Interventions
PROCEDURE

ERCP

endoscopy, retrograde cholangio-pancreaticography.

DRUG

Diclofenac hydroxyethylpyrrolidine

DRUG

Normal Saline

Trial Locations (1)

970

SAH hospital, Nablus

All Listed Sponsors
lead

Specialized Arab Hospital

OTHER

NCT01946984 - Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis | Biotech Hunter | Biotech Hunter